Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Inovio plans first clinical trial for its HCV vaccine in 2013
Inovio Pharmaceuticals could start clinical trials of SynCon HCV, its hepatitis C DNA vaccine, this year. Preclinical research found strong T-cell responses in the blood and liver. VGX International is paying for preclinical tests and human trials.
Or we can send an email on your behalf